| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 07.02.2000 (8846
dage). |
Ingen historik.
| Branche | | Forskning og eksperimentel udvikling indenfor bioteknologi (721100). |
| Sidst opdateret den 20.12.2007 og
angivet som gældende fra 01.01.2008 (5961
dage). |
| Historik | Start | Stop |
|---|
| Forskning og eksperimentel udvikling indenfor bioteknologi (721100) | 01.01.2008 | |
| Forskning og udvikling inden for naturvidenskab og teknik (731000) | 17.04.2000 | 31.12.2007 |
| Uoplyst (980000) | 07.02.2000 | 16.04.2000 |
| Revisionfravalgt | | false. |
| Sidst opdateret den 11.03.2015 og
angivet som gældende fra 07.02.2000 (8846
dage). |
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
| Telefonnummer | | 44608800. |
| Sidst opdateret den 02.02.2004 og
angivet som gældende fra 23.01.2004 (7400
dage). |
Ingen historik.
| Navne | | SOPHION BIOSCIENCE A/S. |
| Sidst opdateret den 26.06.2000 og
angivet som gældende fra 20.06.2000 (8712
dage). |
| Historik | Start | Stop |
|---|
| SOPHION BIOSCIENCE A/S | 20.06.2000 | |
| IONS A/S | 14.03.2000 | 19.06.2000 |
| KR 228 A/S | 07.02.2000 | 13.03.2000 |
| Historik | Start | Stop |
|---|
| BIOLIN SCIENTIFIC A/S | 07.02.2000 | 15.02.2017 |
| Virksomheden har ikke ændret Binavne i
sin
levetid. |
Ingen nuværende registrering.
| Tegningsregel | | Selskabet tegnes af den samlede bestyrelse eller af to af bestyrelsens medlemmer i forening eller af et bestyrelsesmedlem i fællesskab med en direktør. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 27.10.2011 (4566
dage). |
| Fortolkning
(3 tegningsmuligheder)
| | bestyrelsen |
| 2 bestyrelsesmedlemmer + |
| 1 bestyrelsesmedlem + 1 direktør |
Ingen historik.
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:Dansk Revision Slagelse Godkendt revisionsaktieselskab
Revisionsvirksomhedens CVR-nr.:29919801
Beskrivelse af revisor:State authorized public accountant
Virksomhedens regnskabsklasse:Reporting class C, medium-size enterprise
Grundlag for konklusion (revision):Basis for Opinion We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the “Auditor’s Responsibilities for the Audit of the Financial Statements” section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (including International Independence standards) (IESBA Code), together with the ethical requirements, that are relevant to our audit of the financial statements in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):Opinion stWe have audited the financial statements of Sophion Bioscience A/S for the financial year 1 January 2022 – st31 December 2022, which comprise income statement, balance sheet, statement of changes in equity, notes and a summary of significant accounting policies. The Financial Statements are prepared under the Danish Financial Statements Act. stIn our opinion, the Financial Statements give a true and fair view of the Company’s financial position at 31ststDecember 2022, and of the results of the Company operations for the financial year 1 January 2022 – 31December 2022 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on Management’s Review Management is responsible for Management’s Review. Our opinion on the Financial Statements døs not cover Management’s Review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the Financial Statements, our responsibility is to read Management’s Review and, in doing so, consider whether Management’s Review is materially inconsistent with the Financial State-ments or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether Management’s Review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that Management’s Review is in accordance with the Financial Statements and has been prepared in accordance with the requirements of the Danish Financial Statement Acts. We did not identify any material misstatement of Management’s Review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration